Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis.

Since biologics became available, corticosteroid use appears to have decreased, with more appropriate use. Furthermore, use of biologics may reduce surgery rates, particularly in patients with CD. UMIN Clinical Trials Registry; UMIN000035384.